Cargando…
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Current COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARS-CoV-2 variants are continuously evolving, and development of new accessible COVID-19 vaccines is essential to mitigate the pandemic. Here,...
Ejemplares similares
-
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
por: Fernández-Bastit, Leira, et al.
Publicado: (2021) -
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
por: Prenafeta, Antoni, et al.
Publicado: (2023) -
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
por: Usai, Carla, et al.
Publicado: (2022) -
Susceptibility of Domestic Goat (Capra aegagrus hircus) to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.351/Beta Variant
por: Fernández-Bastit, Leira, et al.
Publicado: (2022) -
Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses
por: Fernández-Bellon, Hugo, et al.
Publicado: (2021)